EP Patent

EP3672973A4 — Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof

Assigned to Js Innopharm (shanghai) Ltd · Expires 2021-05-26 · 5y expired

What this patent protects

Patent listed against Pemazyre.

Drugs covered by this patent

Patent Metadata

Patent number
EP3672973A4
Jurisdiction
EP
Classification
—
Expires
2021-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Js Innopharm (shanghai) Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.